Cargando…
Metformin: update on mechanisms of action and repurposing potential
Currently, metformin is the first-line medication to treat type 2 diabetes mellitus (T2DM) in most guidelines and is used daily by >200 million patients. Surprisingly, the mechanisms underlying its therapeutic action are complex and are still not fully understood. Early evidence highlighted the l...
Autores principales: | Foretz, Marc, Guigas, Bruno, Viollet, Benoit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153049/ https://www.ncbi.nlm.nih.gov/pubmed/37130947 http://dx.doi.org/10.1038/s41574-023-00833-4 |
Ejemplares similares
-
Role of Mitochondria in the Mechanism(s) of Action of Metformin
por: Vial, Guillaume, et al.
Publicado: (2019) -
AMPK is not required for the effect of metformin on the inhibition of BMP6-induced hepcidin gene expression in hepatocytes
por: Deschemin, Jean-Christophe, et al.
Publicado: (2017) -
Adenosine-Mono-Phosphate-Activated Protein Kinase-Independent Effects of Metformin in T Cells
por: Zarrouk, Marouan, et al.
Publicado: (2014) -
Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
por: Stephenne, X., et al.
Publicado: (2011) -
Activation of AMPK for a Break in Hepatic Lipid Accumulation and Circulating Cholesterol
por: Foretz, Marc, et al.
Publicado: (2018)